Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44045 Riverside Pkwy
Leesburg, VA 20176Phone+1 703-858-6000Fax+1 703-858-6900
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Molecular Genetic Pathology, 2017 - 2018
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 2013 - 2017
- Jilin UniversityClass of 2001
Certifications & Licensure
- IL State Medical License 2018 - 2026
- VA State Medical License 2022 - 2026
- IN State Medical License 2019 - 2025
- PA State Medical License 2018 - 2022
- OH State Medical License 2013 - 2017
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Molecular Genetic Pathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 16 citationsDo proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysisYue Chen, Chenyu Sun, Yile Wu, Xin Chen, Sujatha Kailas
Journal of Cancer Research and Clinical Oncology. 2021-02-11 - 46 citationsBeneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodyniaGuangyuan Li, Jie Tang, Yunpeng Du, Chieh Allen Lee, Timothy S. Kern
Molecular Vision. 2011-12-06 - 12 citationsPHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling.Xiaoqi Wang, Guangyuan Li, Sanjay Koul, Rieko Ohki, Matthew Maurer
Oncotarget. 2018-05-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: